EUR J CLIN INVEST
ISSN：0014-2972 E-ISSN：1365-2362 出版商：Wiley 国家：GERMANY 周期：Monthly
| 收录情况 | h-index：98 CiteScore：5.70 |
EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic| molecular| cellular| or physiological basis of human biology and disease| as well as research that addresses prevalence| diagnosis| course| treatment| and prevention of disease. We are primarily interested in studies directly pertinent to humans| but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory| clinical| and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials| original articles (also including randomized clinical trials| systematic reviews and meta-analyses)| reviews (narrative reviews)| opinion articles (including debates| perspectives and commentaries); and letters to the Editor.
数据整理自公开网络的投稿反馈，仅供参考。
